Anna OrlovaCEO and Co-founder at RIANA Therapeutics GmbHSpeaker
Profile
Anna Orlova, PhD co-founder and CEO, has been leading RIANA Therapeutics since the company's inception in February 2023. With a PhD in Molecular Biology from the University of Vienna, Anna made groundbreaking discoveries of novel STAT5 inhibitors during her doctoral studies, laying the foundation for the company's innovative approach to drug development. She has co-authored 20 peer-reviewed scientific publications and has an h-index of 12.